68 Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer.
George HrubyThomas EadeLouise EmmettBao HoEd HsiaoGeoff SchembriLinxin GuoCarolyn KwongJulia HunterKeelan ByrneAndrew KneebonePublished in: Asia-Pacific journal of clinical oncology (2018)
PSMA-PET/CT identified the primary in 99% of patients, and altered staging in 21% of men with intermediate or high-risk prostate cancer referred for definitive EBRT compared to CT, bone scan and multiparametric MRI. Following this audit, we recommend the routine use of PSMA-PET/CT prior to EBRT in this patient group.
Keyphrases
- pet ct
- prostate cancer
- positron emission tomography
- radical prostatectomy
- computed tomography
- end stage renal disease
- contrast enhanced
- newly diagnosed
- magnetic resonance imaging
- ejection fraction
- prognostic factors
- locally advanced
- case report
- dual energy
- bone mineral density
- image quality
- radiation therapy
- middle aged
- clinical practice
- lymph node
- body composition
- diffusion weighted imaging
- radiation induced
- replacement therapy
- pet imaging
- smoking cessation
- rectal cancer